Skip to main content
. Author manuscript; available in PMC: 2013 Dec 16.
Published in final edited form as: Int J Gynecol Cancer. 2013 Jul;23(6):10.1097/IGC.0b013e3182994365. doi: 10.1097/IGC.0b013e3182994365

Table 1. Patient Demographic and Clinical Characteristics (N = 47).

Age at diagnosis (years) Median (IQR) 57.3 46.8-61.2
Age at genetic counseling (years) Median (IQR) 58.8 50.9-63.9
Time from diagnosis to counseling (months) Median (IQR) 11.5 3.6-48.6
N = 47 %
Race
Caucasian 46 97.9
Black 1 2.1
Tumor site
Ovary 38 80.9
Fallopian Tube 2 4.3
Primary Peritoneal 7 14.9
Stage
I 7 14.9
II 3 6.4
III 32 68.1
IV 4 8.5
Unstaged 1 2.2
Histology
High-grade serous 23 48.9
Mixed tumor 9 19.2
Low-grade/borderline 7 14.9
Endometrioid 3 6.4
Clear cell 3 6.4
Other 2 4.3
Highest Education Level
High School 18 38.3
College 18 38.3
Post-college degree 11 23.4
Disease status at the time of genetic counseling
No evidence of disease 23 48.9
Recurrence 21 44.7
Progressive 3 6.4
Family History of Breast Cancer
Yes 20 42.6
No 27 57.5
Family History of Ovarian, Tubal or Peritoneal Cancer
Yes 10 21.3
No 37 78.7

IQR – Interquartile Range